Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-010533
Filing Date
2025-05-15
Accepted
2025-05-15 08:20:43
Documents
52
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 519826
2 EX-31.1 ex31-1.htm EX-31.1 20352
3 EX-32.1 ex32-1.htm EX-32.1 4877
  Complete submission text file 0001641172-25-010533.txt   2861823

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE pulm-20250331.xsd EX-101.SCH 26393
5 XBRL CALCULATION FILE pulm-20250331_cal.xml EX-101.CAL 36185
6 XBRL DEFINITION FILE pulm-20250331_def.xml EX-101.DEF 83301
7 XBRL LABEL FILE pulm-20250331_lab.xml EX-101.LAB 209919
8 XBRL PRESENTATION FILE pulm-20250331_pre.xml EX-101.PRE 157679
54 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 318716
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 25948882
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)